AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2014
Mar 28, 2014
35134_dirs_2014-03-28_b845a282-1864-4f3b-bc27-f1f052f81ce5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-03-26
Reporting Person: Milligan John C.K. IV (Director, President/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-26 | Common Stock | S | 353412 | $6.6971 | Disposed | 3892187 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1722419 | Direct |
Footnotes
F1: By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended 11/22/2011.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16